HAI Book 2025 - Flipbook - Page 52
Transcutaneous auricular vagus nerve
stimulation improves learning and sleep-wake
quality in older APOE-ε4 carriers
Biological-clinical mismatch reflects copathology and vulnerability to
neurodegeneration
Validation of PET spatial extent as sensitive
amyloid biomarker in early stages of amyloidosis
Developing a novel reference region for PI-2620PET imaging to facilitate assessment of 4repeat tauopathies
P-TAU217, GFAP, and NFL plasma biomarker
associations with demographic, medical and
neurocognitive features from middle-aged
through older adulthood
DeepSUVR: Using temporal constraints to
improve tau quantification
Increasing the granularity of tau-PET Braak
staging using medial temporal lobe
segmentations to detect early memory
impairment
The universal tau PET scale (Uni�㔏) for
Flortaucipir, MK6240, PI2620 and RO948
harmonization
Assessing the relationship between
neuropsychiatric symptoms, amyloid and tau
pathology, and white matter hyperintensity
volume across sexes in preclinical Alzheimer9s
disease
Unveiling the heterogeneity of tau spreading in
aging and Alzheimer's disease using polygenic
combinations: Towards personalized models
Regional amyloid and tau: Exploring regional
sex-based differences in a middle-aged
community-based cohort
Comparison of topographical patterns of
abnormalities of the tau PET tracers
[18F]Flortaucipir, [18F]MK6240, [18F]PI2620,
and [18F]RO948
Subtle cognitive deficits detected through
routine in-office tests are associated with global
A´ and temporal tau in cognitively unimpaired
individuals
Estradiol-dependent associations between
sleep complaints and tau deposition in women at
elevated AD risk
Impact of age and sex on extra-cerebral offtarget binding in tau PET scans (18F-FTP)
Metabolic inefficiency is associated with
regional vulnerability to tau deposition
Relationship between Polygenetic Risk Score of
BrainAge and plasma biomarkers in the
A4/Elearn Study
Combined impact of plasma phospho-tau 217
and NfL on longitudinal domain-specific
cognitive decline
HAI2025 - 52
Marion Baillet, Athinoula A. Martinos Center for
Biomedical Imaging, Department of Radiology,
Massachusetts General Hospital, Boston, MA,
US
Christopher Brown, Department of Neurology,
University of Pennyslvania, Philadelphia, PA,
US
Grace Del Carmen Montenegro, Department of
Radiology, Massachusetts General Hospital,
Harvard Medical School, Boston, MA, US
Lukas Frontzkowski, Institute for Stroke and
Dementia Research (ISD), Munich, DE
Steven Arnold, Massachusetts General
Hospital, Harvard Medical School, Boston, MA,
US
Pierrick Bourgeat, CSIRO Health and
Biosecurity, Brisbane, AU
Etienne Aumont, McGill University Research
Centre for Studies in Aging, Montréal, QC, CA
Guilherme Povala, University of Pittsburgh,
Department of Psychiatry, Pittsburgh, PA, US
Aurélie Garrone, Douglas Mental Health
University Institute, Montreal, QC, CA
Ibai Diez, Gordon Center for Medical Imaging,
Department of Radiology, Massachusetts
General Hospital, Harvard Medical School,
Boston, MA, USA, Boston, MA, US
Diana S Guzmán, Columbia University Medical
Center, New York, NY, US
Livia Amaral, University of Pittsburgh,
Department of Psychiatry, Pittsburgh, PA, US
Cynthia Felix, Department of Psychiatry,
University of Pittsburgh, Pittsburgh, PA, US
Sarah Banks, SDSU/UC San Diego Joint
Doctoral Program in Clinical Psychology, San
Diego, CA, US
Sujala Ghatamaneni, Department of Radiology,
Mayo Clinic, Rochester, MN, US
Jenna Adams, University of California, Irvine,
Irvine, CA, US
Jorge Garcia Condado, Computational
Neuroimaging Lab, Biobizkaia Health Research
Institute, Barakaldo, ES
Hiroko Dodge, Harvard Medical School,
Boston, MA, US
